News | November 08, 2007

BC Cancer Agency Pioneers Improved Radiotherapy Treatment

November 9, 2007 - Clinicians at BC Cancer Agency have treated a prostate cancer patient with a technique, called volumetric arc therapy (VMAT), allowing clinicians to deliver a single treatment to their 72-year-old patient in less than two minutes.

The VMAT treatment is an advanced form of intensity modulated radiation therapy (IMRT), which has the potential to measurably improve treatment precision by sparing more healthy tissue in addition to making treatments much faster and more comfortable for patients. It was made possible by software innovations developed by BC Cancer Agency clinicians together with an advanced medical linear accelerator and beam-shaping accessory from Varian Medical Systems.

Karl Otto, PhD, a medical physicist at the BC Cancer Agency, developed a special software algorithm that made it possible for his clinic to deliver the VMAT treatment. "The algorithm is designed to generate highly conformal dose distributions while taking advantage of the specific capabilities of the Varian linear accelerator," he said.

Building on Otto's work, Varian engineers have developed Varian's new RapidArc radiotherapy technology, which was exhibited for the first time at the American Society for Therapeutic Radiology and Oncology (ASTRO). Varian's RapidArc product for VMAT can deliver intensity-modulated radiotherapy treatments two to eight times faster than was previously possible. It is currently pending FDA 510(k) clearance and not yet available for sale in the U.S.

For more information: www.varian.com

Related Content

Hypofractionated Radiation Provides Same Prostate Cancer Outcomes as Conventional Radiation
News | Intensity Modulated Radiation Therapy (IMRT) | October 31, 2018
An analysis led by researchers at Philadelphia’s Fox Chase Cancer Center found treating localized prostate cancer with...
IBA Completes Installation of Two Proteus One Proton Therapy Systems in Japan
News | Proton Therapy | July 30, 2018
IBA (Ion Beam Applications S.A.) announced that they completed the first two installations of the Proteus One proton...
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
UZ Leuven Treats First European Patient on Varian Halcyon Cancer Treatment System
News | Intensity Modulated Radiation Therapy (IMRT) | October 25, 2017
Varian recently announced an 80-year-old male with head and neck cancer became the first patient in Europe to be...
Varian Receives FDA 510k Clearance for Halcyon Treatment System
Technology | Intensity Modulated Radiation Therapy (IMRT) | July 05, 2017
Varian Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Halcyon system,...
First New York Metropolitan Hospital Treats Cancer Patients With Accuray Radixact System
News | Image Guided Radiation Therapy (IGRT) | July 03, 2017
Accuray Inc. and Montefiore Einstein Center for Cancer Care (MECCC), part of the Montefiore Health System (MHS),...
IUCT Oncopole Installs First Radixact Radiotherapy System in France
News | Intensity Modulated Radiation Therapy (IMRT) | June 20, 2017
Accuray Inc. announced that the University Cancer Institute of Toulouse Oncopole (IUCT Oncopole) in Toulouse, France,...
cervical and endometrial cancer, IMRT, intensity modulated radiation therapy, side effects, ASTRO 2016 study
News | Intensity Modulated Radiation Therapy (IMRT) | September 29, 2016
Patients with cervical and endometrial cancer have fewer gastrointestinal and genitourinary side effects and experience...